Vernieri, C., Galli, F., Ferrari, L., Marchetti, P., Lonardi, S., Maiello, E., . . . Di Bartolomeo, M. (2019). Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis. Oncologist.
Chicago-stil citatVernieri, Claudio, et al. "Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy On the Outcome of Patients With Resected Colon Cancer: A TOSCA Study Subanalysis." Oncologist 2019.
MLA-referensVernieri, Claudio, et al. "Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine‐Oxaliplatin Chemotherapy On the Outcome of Patients With Resected Colon Cancer: A TOSCA Study Subanalysis." Oncologist 2019.